Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Leukemia. 2010 Jun 10;24(8):1406–1411. doi: 10.1038/leu.2010.129

Table 1.

Patient Characteristics

Characteristic Number evaluated or evaluable Median (range)
Age, years 42 63 (44–81)
Gender, male (%) 42 21 (50)
Durie Salmon II/III (%) 37 16 (39)/21 (51)
Durie Salmon A/B (%) 41 34 (83)/7 (17)
Isotype: IgG/IgA/Light chain only (%) 38 25 (60)/7 (17)/6 (14)
Hemoglobin, g/dL 42 9.7 (7.6–15.3)
Creatinine, mg/dL 42 1.2 (0.6–3.8)
Calcium, mg/dL 42 8.8 (6.63–15.5)
Serum M-spike, g/dL 37 4.4 (1.4–8.8)
Urine M-spike, g/day 20 389 (10–4713)
Bone marrow plasmacytosis 50 (1,100)
Beta-2 microglobulin, mg/mL (range) 42 7.7 (2.5–31.9)
 B2M ≥ 5.5 32 (76)
PCLI, % (range)§ 33 1.6 (0 – 5)
 PCLI ≥ 1 17 (40)
Deletion 13q-*(%) 41 6 (14)
Translocation (4;14)(%) 24 4 (10)
Translocation (14;16)(%) 24 0 (0)
Deletion 17p (%) 24 2 (5)
*

By metaphase cytogenetics